Insider Transactions in Q1 2025 at Cytosorbents Corp (CTSO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2025
|
Michael G. Bator Director |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
10,000
+6.2%
|
$10,000
$1.13 P/Share
|
|
Feb 24
2025
|
Vincent Capponi President and COO |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
12,000
+1.74%
|
$12,000
$1.13 P/Share
|
|
Feb 24
2025
|
Alan D. Sobel Director |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
21,950
+13.09%
|
$21,950
$1.13 P/Share
|
|
Feb 24
2025
|
Phillip P. Chan Chief Executive Officer |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
34,168
+2.61%
|
$34,168
$1.13 P/Share
|
|
Feb 24
2025
|
Peter J Mariani Chief Financial Officer |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
32,625
+6.54%
|
$32,625
$1.13 P/Share
|
|
Jan 17
2025
|
Michael G. Bator Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
15,879
+10.1%
|
$15,879
$1.0 P/Share
|
|
Jan 17
2025
|
Peter J Mariani Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
32,625
+6.99%
|
$32,625
$1.0 P/Share
|
|
Jan 17
2025
|
Phillip P. Chan Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
90,832
+6.81%
|
$90,832
$1.0 P/Share
|
|
Jan 17
2025
|
Alan D. Sobel Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
21,950
+15.06%
|
$21,950
$1.0 P/Share
|
|
Jan 17
2025
|
Efthymios Deliargyris Chief Medical Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
16,233
+3.87%
|
$16,233
$1.0 P/Share
|
|
Jan 17
2025
|
Vincent Capponi President and COO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
31,760
+4.56%
|
$31,760
$1.0 P/Share
|